Zealand Pharma to Take Part in Jefferies Global Healthcare Conference
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 12 2025
0mins
Should l Buy ?
Source: Globenewswire
Event Participation: Zealand Pharma's CEO, Adam Steensberg, will participate in a fireside chat at the Jefferies Global Healthcare Conference in London on November 19, 2025, at 10:30am GMT.
Webcast Availability: A live audio webcast of the chat will be available online and can be accessed through Zealand Pharma's website, where a recording will also be archived.
Company Overview: Zealand Pharma is a biotechnology company specializing in peptide-based medicines, with over 10 drug candidates in clinical development, including two on the market and three in late-stage development.
Contact Information: The press release includes contact details for key personnel in investor relations and media communications at Zealand Pharma.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
